Mixed effects of long-term frozen storage on cord tissue stem cells

Cytotherapy

Volumn 16, Issue 9, 2014, Pages 1313-1321

  Badowski, Michael ^a   Muise, Angela ^a   Harris, David T ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Banking; Cord tissue; Cryopreservation; Mesenchymal stromal cells; Regenerative medicine; Stem cells; Tissue engineering

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; HERMES ANTIGEN; THY 1 ANTIGEN;

ADIPOCYTE; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CELL GROWTH; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; CRYOPRESERVATION; EXPLANT; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; MESENCHYMAL STROMA CELL; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; THAWING; TISSUE PRESERVATION; UMBILICAL CORD; ADIPOGENESIS; BONE DEVELOPMENT; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CYTOLOGY; PHYSIOLOGY; PROCEDURES; STEM CELL; TIME;

ADIPOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CRYOPRESERVATION; HUMANS; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; STEM CELLS; TIME FACTORS; UMBILICAL CORD;

EID: 84905440290     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2014.05.020     Document Type: Article

References (40)

1. Norambuena G.A., Khoury M., Jorgensen C. Mesenchymal stem cells in osteoarticular pediatric diseases: an update. Pediatr Res 2012, 71:452-458.
2. Pati S., Gerber M.H., Menge T.D., Wataha K.A., Zhao Y., Baumgartner J.A., et al. Bone marrow derived mesenchymal stem cells inhibit inflammation and preserve vascular endothelial integrity in the lungs after hemorrhagic shock. PLoS One 2011, 6:e25171.
3. See E.Y., Toh S.L., Goh J.C. Multilineage potential of bone-marrow-derived mesenchymal stem cell sheets: implications for tissue engineering. Tissue Eng Part A 2010, 6:1421-1431.
4. Strioga M., Viswanathan S., Darinskas A., Slaby O., Michalek J. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev 2012, 21:2724-2752.
5. Lindroos B., Suuronen R., Miettinen S. The potential of adipose stem cells in regenerative medi-cine. Stem Cell Rev 2011, 2:269-291.
6. Zhang H., Zhang B., Tao Y., Cheng M., Hu J., Xu M., Chen H. Isolation and characterization of mesenchymal stem cells from whole human umbilical cord applying a single enzyme approach. Cell Biochem Funct 2012, 30:643-649.
7. Lu L.L., Liu Y.J., Yang S.G., Zhao Q.J., Wang X., Gong W., et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 2006, 91:1017-1026.
8. Capelli C., Gotti E., Morigi M., Rota C., Weng L., Dazzi F., et al. Minimally manipulated whole human umbilical cord is a rich source of clinical-grade human mesenchymal stromal cells expanded in human platelet lysate. Cytotherapy 2011, 13:786-801.
9. Marmotti A., Mattia S., Bruzzone M., Buttiglieri S., Risso A., Bonasia D.E., et al. Minced umbilical cord fragments as a source of cells for orthopaedic tissue engineering: an in vitro study. Stem Cells Int 2012, 2012:326813.
10. Bosch J., Houben A.P., Radke T.F., Stapelkamp D., Bünemann E., Balan P., et al. Distinct differentiation potential of "MSC" derived from cord blood and umbilical cord: are cord-derived cells true mesenchymal stromal cells?. Stem Cells Dev 2012, 21:1977-1988.
11. Nekanti U., Mohanty L., Venugopal P., Balasubramanian S., Totey S., Ta M. Optimization and scale-up of Wharton's jelly-derived mesenchymal stem cells for clinical applications. Stem Cell Res 2010, 5:244-254.
12. Pilz G.A., Ulrich C., Ruh M., Abele H., Schäfer R., Kluba T., et al. Human term placenta-derived mesenchymal stromal cells are less prone to osteogenic differentiation than bone marrow-derived mesenchymal stromal cells. Stem Cells Dev 2011, 20:635-646.
13. Girdlestone J., Limbani V.A., Cutler A.J., Navarrete C.V. Efficient expansion of mesenchymal stromal cells from umbilical cord under low serum conditions. Cytotherapy 2009, 11:738-748.
14. Choudhery M.S., Badowski M.S., Muise A., Harris D.T. Comparison of human adipose and cord tissue derived mesenchymal stem cells. Cytotherapy 2013, 15:330-343.
15. Choudhery M.S., Khan M., Mahmood R., Mehmood A., Khan S.N., Riazuddin S. Bone marrow derived mesenchymal stem cells from aged mice have reduced wound healing, angiogenesis, proliferation and anti-apoptosis capabilities. Cell Biol Int 2012, 36:747-753.
16. Kim W.K., Jung H., Kim D.H., Kim E.Y., Chung J.W., Cho Y.S., et al. Regulation of adipogenic differentiation by LAR tyrosine phosphatase in human mesenchymal stem cells and 3T3-L1 preadipoctes. J Cell Sci 2009, 122:4160-4167.
17. Broxmeyer H.E., Gluckman E., Auerbach A., Douglas G.W., Friedman H., Cooper S., et al. Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/progenitor cells. Int J Cell Cloning 1990, 8(Suppl 1):76-89. discussion 89-91.
18. Gluckman E., Broxmeyer H.A., Auerbach A.D., Friedman H.S., Douglas G.W., Devergie A., et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989, 321:1174-1178.
19. Gluckman E. Stem cell harvesting from cord blood: a new perspective. Peripheral blood stem cell autographs 1990, 1-20. Springer Verlag, Berlin, Heidelberg. H.A. Wunder (Ed.).
20. Broxmeyer H.A., Kurtzberg J., Gluckman E., Auerbach A., Douglas G., Cooper S., et al. Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation: an expanded role for cord blood transplantation. Blood Cells 1991, 17:330-337.
21. Broxmeyer H.E., Kurtzberg J., Gluckman E., Auerbach A.D., Douglas G., Cooper S., et al. Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation. Blood Cells 1991, 17:313-329.
22. Broxmeyer H.E., Douglas G.W., Hangoc G., Cooper S., Bard J., English D., et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A 1989, 86:3828-3832.
23. Vilmer E., Sterkers G., Rahimy C., Denamur E., Elion J., Broyart A., et al. HLA-mismatched cord-blood transplantation in a patient with advanced leukemia. Transplantation 1992, 53:1155-1157.
24. Wagner J.E., Kernan N.A., Steinbuch M., Broxmeyer H.E., Gluckman E. Allogeneic sibling umbilical cord blood transplantation in children with malignant and nonmalignant disease. Lancet 1995, 346:214-219.
25. Butler M.G., Menitove J.E. Umbilical cord blood banking: an update. J Assist Reprod Genet 2011, 28:669-676.
26. Harris D.T., Schumacher M.J., Rychlik S., Booth A., Acevedo A., Rubinstein P., et al. Collection, separation and cryopreservation of umbilical cord blood for use in transplantation. Bone Marrow Transplant 1994, 13:135-143.
27. Broxmeyer H.E., Srour E.R., Hangoc G., Cooper S., Anderson S.A., Bodine D.A. High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Proc Natl Acad Sci U S A 2003, 100:645-650.
28. McGuckin C.P., Forraz N., Baradez M.O., Navran S., Xhao J., Urban R., et al. Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Prolif 2005, 38:245-255.
29. McGuckin C.P., Forraz N., Allouard Q., Pettengell R. Umbilical cord blood stem cells can expand hematopoietic and neuroglial progenitors in vitro. Exp Cell Res 2004, 295:350-359.
30. Rogers I., Yamanaka N., Bielecki R., Wong C.J., Chua S., et al. Identification and analysis of in vitro cultured CD45-positive cells capable of multi-lineage differentiation. Exp Cell Res 2007, 313:1839-1852.
31. Kucia M., Halasa M., Wysoczynski M., Baskiewicz-Masiuk M., Moldenhawer S., Zuba-Surma E., et al. Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human umbilical cord blood-preliminary report. Leukemia 2007, 21:297-303.
32. Harris D.T., He X., Badowski M., Nichols J.C. Regenerative medicine of the eye: a short review. Stem cell repair regeneration 2008, vol. 3:211-225. Imperial College Press, London.
33. Sunkomat J.N.E., Goldman S., Harris D.T. Cord blood-derived MNCs delivered intracoronary contribute differently to vascularization compared to CD34+ cells in the rat model of acute ischemia. J Mol Cell Cardiol 2007, 42(Suppl 1):S97.
34. Harris D.T., Badowski M., Ahmad N., Gaballa M. The potential of cord blood stem cells for use in regenerative medicine. Expert Opin Biol Ther 2007, 7:1311-1322.
35. Xue G., He M., Zhao J., Chen Y., Tian Y., Zhao G. Intravenous umbilical cord mesenchymal stem cell infusion for the treatment of combined malnutrition nonunion of the humerus and radial nerve injury. Regen Med 2011, 6:733-741.
36. Wu K.H., Chan C.K., Tsai C., Chang Y.H., Sieber M., Chiu T.H., et al. Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells. Transplantation 2011, 91:1412-1416.
37. Liang J., Zhang H., Hua B., Wang H., Wang J., Han Z., Sun L. Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis. Mult Scler 2009, 15:644-646.
38. Liang J., Gu F., Wang H., Hua B., Hou Y., Shi S., et al. Mesenchymal stem cell transplantation for diffuse alveolar hemorrhage in SLE. Nat Rev Rheumatol 2010, 6:486-489.
39. Lindenmair A., Hatlapatka T., Kollwig G., Hennerbichler S., Gabriel C., Wolbank S., et al. Mesenchymal stem or stromal cells from amnion and umbilical cord tissue and their potential for clinical applications. Cells 2012, 1:1061-1088.
40. Gonzalo-Daganzo R., Regidor C., Martin-Donaire T., Rico M.A., Bautista G., Krsnik I., et al. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults. Cytotherapy 2009, 11:278-288.